ArticleOpen Access http://dx.doi.org/10.26855/ijcemr.2025.03.007
Identifying Subgroups and Influencing Factors of Postoperative Patients with Liver Cancer
Ping Wang, Meixiang Wang*
School of Nursing, Hainan Vocational University of Science and Technology, Haikou 571137, Hainan, China.
*Corresponding author: Meixiang Wang
Published: April 02, 2025
Abstract
Objective: To explore the latent classes of postoperative symptoms and their influencing factors in patients with primary liver cancer. Methods: A convenience sampling method was used to select 280 liver cancer patients who underwent surgery at a tertiary hospital in Haikou from January 2023 to January 2025. Data were collected using a general information questionnaire and the Chinese version of the Anderson Symptom Assessment Scale. Latent class analysis was employed to identify the potential categories of symptoms, and univariate analysis and multivariate logistic regression analysis were used to explore the influencing factors for each latent category. Results: Postoperative symptoms in liver cancer patients could be classified into three latent categories: a high-symptom group (52.0%), a high-gastrointestinal symptom group (36.1%), and a low-symptom group (11.9%). Educational level and liver function grade were found to be influencing factors for the latent symptom categories in these patients. Conclusion: The postoperative symptoms of liver cancer patients exhibit heterogeneity. Patients with lower educational levels are more likely to belong to the high-symptom group, while those with Child-Pugh class B were more prone to the high gastrointestinal symptom group. Clinical healthcare providers should effectively identify the latent characteristics of different categories and implement targeted interventions to alleviate the symptom burden of these patients.
Keyword
Liver cancer; Latent class analysis; Symptom management; Influencing factors
References
[1] Chen N, Chen K, Wang Y, et al. The impact of symptom distress on health-related quality of life in liver cancer patients receiving arterial chemoembolization: the mediating role of hope. BMC Gastroenterol. 2022;22(1):456.
[2] Miaskowski C, Barsevick A, Berger A, et al. Advancing symptom science through symptom cluster research: expert panel proceedings and recommendations. J Natl Cancer Inst. 2017;109(4).
[3] Wang Y, Kim E, Yi Z. Robustness of latent profile analysis to measurement noninvariance between profiles. Educ Psychol Meas. 2022;82(1):5-28.
[4] Wang X, Wang Y, Guo H, et al. Chinese version of the M. D. Anderson Symptom Inventory: validation and application of symptom measurement in cancer patients. Cancer. 2004;101(8):1890-901.
[5] Lu L, Guo W, Chen J, et al. Postoperative subphenotypes modified the hepatoma arterial-embolization prognostic score: a novel smHAP-II nomogram. J Cancer. 2024;15(10):2940-7.
[6] Kondili LA, Lazarus JV, Jepsen P, et al. Inequities in primary liver cancer in Europe: the state of play. J Hepatol. 2024;80(4):645-60.
[7] Pizzato M, di Maso M, Collatuzzo G, et al. Cancer mortality associated with low education in Italy. J Public Health (Oxf). 2023;45(4):822-8.
[8] EASL Clinical Practice Guidelines for the management of patients with decompensated cirrhosis. J Hepatol. 2018;69(2):406-60.
[9] Newman EM, Rowland A. A physiologically based pharmacokinetic model to predict the impact of metabolic changes associated with metabolic associated fatty liver disease on drug exposure. Int J Mol Sci. 2022;23(19).
Copyright
© 2025 by the author(s).
This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution-NonCommercial-NoDerivatives (CC BY-NC-ND) license, which permits non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited and is not modified or adapted.
https://creativecommons.org/licenses/by-nc-nd/4.0/
How to cite this paper
Identifying Subgroups and Influencing Factors of Postoperative Patients with Liver Cancer
How to cite this paper: Ping Wang, Meixiang Wang. (2025) Identifying Subgroups and Influencing Factors of Postoperative Patients with Liver Cancer. International Journal of Clinical and Experimental Medicine Research, 9(2), 206-211.
DOI: http://dx.doi.org/10.26855/ijcemr.2025.03.007